Many people in poor countries die from diseases that are curable because they cannot afford the medication required. Do you believe that drug companies should make their products available at reduced prices in these countries? Give reasons for your answer and include any relevant examples from your own knowledge and experience.

Many people in developing countries die due to diseases that can be cured because of the high cost of the treatment. So, many argue whether pharmacological companies should offer the medication at lower prices or not. From my point of view, they should offer these medications at a nominal price or even for free. In […]

Drug availability and accessibility has been a priority across the globe for an important reason. Death due to easily preventable diseases can never be justified and should be considered morally degrading. Underdeveloped countries are prone to such injustices and this matter should be of global concern. As such, drug companies should reconsider their marketing goals […]

Citizens of developing countries die from diseases that are curable since they are not able to pay for the treatment. Therefore, many people believe that it is inequitable, so pharmaceutical industries should reduce their medical products so that poor countries can treat diseases that cause problems. From my point of view, there is no need […]

People in less developed countries loose their lives from various diseases that can controlled through medication due to the lack of money. I firmly believe that, the drugs manufacturers should assist the individuals in the specified countries by supplying drugs at low cost that can be afforded by any one even those with low income. […]

The world has rapidly evolved, providing many technological benefits in every sector( like medical and education); however, inflation is still a pressing issue for numerous people in several nations, which prohibit them to access these basic medical treatments , leading them to death. I firmly believe that subsidised prices should be offered by pharmaceutical companies, […]